Dejan Bojanic

Novel trends in high-throughput screening.

Lorenz M Mayr, Dejan Bojanic, D. Bojanic, 2009, Current opinion in pharmacology.

Maximising use of in vitro ADMET tools to predict in vivo bioavailability and safety

Laszlo Urban, Dejan Bojanic, Jianling Wang, 2007, Expert opinion on drug metabolism & toxicology.

A Novel Membrane Potential-Sensitive Fluorescent Dye Improves Cell-Based Assays for Ion Channels

Rory Curtis, Dejan Bojanic, P. Distefano, 2002, Journal of biomolecular screening.

Evaluation of Fluorescence- and Mass Spectrometry—Based CYP Inhibition Assays for Use in Drug Discovery

Laszlo Urban, Bailin Zhang, Dejan Bojanic, 2008, Journal of biomolecular screening.

High-content micronucleus assay in genotoxicity profiling: initial-stage development and some applications in the investigative/lead-finding studies in drug discovery.

Dejan Bojanic, Wilfried Frieauff, D. Bojanic, 2010, Toxicological sciences : an official journal of the Society of Toxicology.